OPTIMIZATION OF RIFAMYCIN B USING NOCARDIA MEDITERRANEA (ATCC 13865) BY FED BATCH MODE IN SHAKE FLASKS

Suneel Kumar Niranjan, Chandrul Kaushal, S K Jain

Abstract


The present study was carried out to evaluate the optimum Production of Rifamycin B by using fed- batch mode in the shake flask at the defenit level of different agitation and aeration rate, amongst different carbohydrate in the form of monoshacride. Amongst the various carbohydrate (Arabinose, Fructose, Galactose, Glucose, Glycerol, Maltose, Mannitol, Sorbitol, and Sucrose) sources maximum, the rifamycin (578 µgml-1) with 10% glucose level was found as compared to control which was (138 ± 2.70µgml-1).The environmental factors such as incubation temperature. The optimum temperature for maximum antibiotic production (525µgml-1) was found to be 29°C, initial pH, aeration and agitation rates were also optimized. The optimum rifamycin yield (950 to 1100µgml-1) was obtained in 1.0 L fermenter with working volume of 1.5 L at 28 °C with initial pH of 6.2 to 6.5. The agitation and aeration were 300 rpm and 0.5 LL-1 min-1respectively.

Keywords: Nocardia mediterranea ATCC 13865, Agitator, Carbohydrate, Rifamycin B, Fed-batch, Optimization.

 


References


El-Tayeb, O.M., Hussein, M. M. M., Salama, A.A. and El-Sedawy, “Optimization of industrial production of rifamycin B by Amycolatopsis mediterranei. III. Production in fed-batch mode in shake flask”, African Journal of Biotechnology, 2004; 3 (8):387-394.

Bapat PM, Wangikar PP, “Optimization of Rifamycin B fermentation in shake flasks via a machine-learning-based approach”, Biotechnol Bioeng, 2004; 86:201–208.

El Enshasy HA, El Baz AF, and Ammar EM. “Simultaneous production and decomposition of different Rifamycins during Amycolatopsis mediterranei growth in shake flask and in stirred tank bioreactor”, Current Research and Educational Topics and Trends in Applied Microbiology A. Méndez-Vilas,Formatax (Ed.), 2005; 315-21

Heinz G. Floss and Tin­Wein Yu, “Rifamycin Mode of Action, Resistance, and Biosynthesis”, Chemical Reviews, 2005; 105(2):621-32

El-Sedawy HF, Hussein MMM, Essam T, El-Tayeb OM, Mohammad FHA. “Scaling Up for the Industrial Production of Rifamycin B Fed-Batch Production Mode in Shake Flasks and Bench-Scale Fermentor”, Ferment Technol,2007; 1(5):2167-72

Jin ZH, Lin JP, Xu ZN, Cen PL. “Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening”, J. Gen. Appl. Microbiol,2002; 48(6):329-334.

JIN Zhi-hua , LIN Jian-ping, CEN Pei-lin, “Scale-up of rifamycin B fermentation with Amycolatoposis”, Mediterranei Journal of Zhejiang University science,2004; 5(12):1590-96

Mandali N, Girijashankar V, Ponamgi SPD, Peela S, Rao LV. “Rifamycin SV production using immobilized cells of Amycolatopsis mediterranei OVA5-E7 in different matrices”, Journal of Chemical and Pharmaceutical Research, 2014; 6(9):298-306

Ates S, Elibol M, Mavituna F. “Production of actinorhodin by Streptomyces coelicolor in batch and fed­batch cultures”, Science Direct, 2010; 32(4):273­278.

Xuan-Tien Doan, Srinivasan R, Bapat PM, Wangikar PP. “Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: A case study with rifamycin B fermentation”, Journal of Biotechnology,2007; 132(2):156-66

Xuan-Tien Doan, Srinivasan R, Bapat PM, Wangikar PP, “Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: A case study with rifamycin B fermentation”. Current Trends in Biotechnology and Pharmacy, 2010; 3(1):153-61


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

footer_848
ISSN: 2250-1177  This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.